GMP: New EMA Reflection Paper on Heparin and further Biological Starting Materials
With our GMP News from 29 February 2012 about FDA\'s Draft Guidance on the qualification of Heparin manufacturers, we\'ve informed you about the latest FDA requirements. The link given in the FDA Draft Guidance to the analytical method is no longer valid. Instead, the analytical procedure for the testing of the quality of Heparin is available via other document.
Źródło wiadomośći: http://www.gmp-compliance.org/eca_news_3065_3065.html